The first domestic herpes zoster vaccine officially listed on June 3, Changchun Baike Biotechnology Co., Ltd. announced that the live attenuated herpes zoster vaccine developed by Changchun Baike Biotechnology Co., Ltd. was officially put on the market at the "academic Symposium on Life cycle Prevention Strategy of Varicella-Zoster virus" sponsored by the China Vaccine Industry Association today. It is reported that this herpes zoster vaccine is the first domestic herpes zoster vaccine approved and issued, extending the age of people to 40 and above, becoming the first live attenuated herpes zoster vaccine for people aged 40 and above in China.